Masimo’s Plethysmograph Variability Index (PVI), a noninvasive measurement that quantifies changes in the plethysmographic waveform derived from pulse oximetry, can provide clinicians with a noninvasive way to monitor functional hemodynamics in their patients.
Clinicians who have evaluated PVI believe this technology will prove to be a valuable clinical tool with significant advantages over currently available indicators of changes in functional hemodynamics that are invasive, operator dependent, often inaccurate and expensive.

Aspect Medical Systems’ FDA-cleared BIS VIEW Monitoring system is the company’s newest stand-alone monitor.
The BIS VIEW offers customers a compact design and simplified operation for lower acuity clinical environments with limited room for monitoring equipment.
BIS monitoring may be used as an aid in monitoring the effects of certain anesthetic agents and may be associated with a reduction in primary anesthetic use and a reduction in emergence and recovery time.

August 17, 2007 – Philips Electronics announced that it will donate an “Imagination Light Canvas,” the first of its kind, to Mercy Health System of Northwest Arkansas for use in the Women’s and Children’s waiting area of the new Mercy hospital opening in Arkansas in 2008.

August 17, 2007 — Advanced BioHealing Inc. (ABH), in collaboration with leaders in wound healing research, released an analysis that demonstrates the value of serial debridement in treating lower extremity wounds.

The manuscript, entitled "Serial Surgical Debridement Increases the Healing Rates of Chronic Lower Extremity Wounds," was presented by David Armstrong, DPM, Ph.D, at the annual meeting of the American Podiatric Medical Association (APMA) in Philadelphia, Pa.

August 17, 2007 - DocuSys Inc., a leading provider of anesthesia information management systems (AIMS) and drug management systems, announced the appointment of two healthcare IT veterans to its senior management staff.

Robert E. Watson is the company’s new president and chief executive officer (CEO). Joseph E. Heins has joined the company as executive vice president and chief operating officer (COO). Robert Hanson, who previously served as president and CEO, is now vice chairman.

August 17, 2007 - Richard J. Rosenbluth, M. D.’s new blog site, SeniorsWithCancer.com, is dedicated to helping senior adults with cancer and their families cope with the disease.

A pioneer in the emerging field of geriatric oncology, Dr.Rosenbluth is chairman of the Geriatric Oncology Program of the Cancer Center at Hackensack University medical center, and Medical Director of the In-House Hospice Program at HUMC.

August 17, 2007 — Anesiva Inc. announced today that the FDA has approved Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system, which provides rapid, topical, local analgesia to reduce the pain associated with venous access procedures, such as IV insertions or blood draws, in children ages three to 18.

Zingo is an easy-to-administer, single-use, needle-free system containing 0.5 mg sterile lidocaine powder. It provides a rapid onset of action, allowing intravenous line placement or venipuncture to begin one to three minutes after administration.

August 17, 2007 — University General Hospital announced that it has been designated as a Bariatric Surgery Center of Excellence by the American Society for Metabolic and Bariatric Surgery.

This designation recognizes surgical programs with demonstrated track record of favorable outcomes in bariatric surgery.

To earn the Center of Excellence designation, University General Hospital underwent a rigorous process during which all aspects of the program’s surgical processes were closely examined and data on surgical outcomes was reviewed and analyzed.

August 17, 2007 – C. R. Bard Inc. announced that it has received FDA approval to market its FLAIR Endovascular Stent Graft to treat stenoses (narrowing) at the venous anastomosis of synthetic arteriovenous (AV) grafts in hemodialysis patients to increase blood flow.

August 17, 2007 - The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine, in MD, has placed an order to add an Elekta Synergy S system to its Leksell Gamma Knife capability, aiming to fight cancer with both intracranial and extracranial resources for whole-body cancer treatment.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now